跳至主要内容
临床试验/NCT00790530
NCT00790530已完成不适用

Automated Telephone Outreach With Speech Recognition to Improve Diabetes Care: A Randomized Controlled Study

Harvard Pilgrim Health Care2 个研究点 分布在 1 个国家目标入组 1,200 人开始时间: 2006年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,200
试验地点
2
主要终点
Completion of dilated eye examination

研究概览

简要总结

The purpose of this study is to evaluate the effectiveness of automated telephone outreach with speech recognition to improve diabetes care.

详细描述

Randomly allocate a total of 1200 health plan members with diabetes to automated telephone outreach with speech recognition (ATO-SR; N = 600) or usual care (N = 600). The intervention is a series of three calls, using automated calls, originating from the health plan, using interactive speech recognition technology, spaced approximately 4-6 weeks apart, to encourage participants to fulfill the recommended testing (dilated eye examinations, glycated hemoglobin, LDL-cholesterol, microalbumin) that had not been performed received in the preceding year.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 18 years or older
  • Diabetes, defined as either 1) filled a prescription for insulin or an oral hypoglycemic agent; or, 2) had two outpatient or one inpatient or two outpatients encounter claims with an ICD9-CM or CPT code indicating diabetes.
  • Gap in a key diabetes management metric as evidenced by no claim for a dilated eye examination in the prior 15 months and no claim for one or more of the following tests: glycated hemoglobin, LDL-cholesterol, or microalbumin. (Individuals with evidence of having received ACE-inhibitors or angiotensin receptor blockers were considered to have had a microalbumin test.)

排除标准

  • No primary care clinician in the data base
  • Those who had previously asked the health plan to exclude them from research or quality improvement
  • Women whose claim records contained diagnoses suggesting gestational diabetes

结局指标

主要结局

Completion of dilated eye examination

时间窗: 12-months following intervention

次要结局

  • Completion of glycated hemoglobin testing (HbA1c)(one-year following intervention)
  • Completion of LDL-cholesterol testing(one year following intervention)
  • Completion of microalbumin testing(one-year following intervention)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验